Internal Medicine, Pulmonary Disease · Inglewood, CA
NPI
1134132798
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
401 S la Brea Ave Ste 205
Inglewood, CA, 90301
Phone (310) 275-7575
Groups this clinician bills Medicare through
Medicare paid, 2024
$661K
8,005 services
Medicare patients, 2024
806
Average age 72
Drug cost, 2024
$175K
2,910 prescriptions
Company payments, 2025
$908
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jamshid Niknam was code 99232 (hospital e&m - subsequent), 3,004 times for 594 patients. In total Jamshid Niknam billed 8,005 services in 16 codes, and Medicare paid $661K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 3,004 | 594 | $69.69 | $209K |
| 99308 SNF E&M | Facility | 1,813 | 24 | $67.35 | $122K |
| 99233 Hospital E&M - Subsequent | Facility | 1,755 | 395 | $105.45 | $185K |
| 99223 Hospital E&M - Initial | Facility | 582 | 519 | $148.30 | $86K |
| 99231 Hospital E&M - Subsequent | Facility | 461 | 146 | $43.53 | $20K |
| 99309 SNF E&M | Facility | 189 | 16 | $97.99 | $19K |
| 99238 Hospital Discharge Management | Facility | 114 | 108 | $71.83 | $8,188 |
| 99222 Hospital E&M - Initial | Facility | 43 | 41 | $113.57 | $4,883 |
By year: 2022 $49K for 537 services; 2023 $465K for 5,688 services; 2024 $661K for 8,005 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jamshid Niknam prescribed most often to Medicare patients was Atorvastatin Calcium, with 169 prescriptions and refills. In total Jamshid Niknam wrote 2,910 Medicare prescriptions that cost $175K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 169 | 174 | 24 | $1,835 |
| Gabapentin Generic | 130 | 131 | 19 | $5,235 |
| Amlodipine Besylate Generic | 115 | 116 | 20 | $865 |
| Levetiracetam Generic | 114 | 114 | 12 | $2,626 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 103 | 104 | 18 | $4,020 |
| Famotidine Generic | 97 | 98 | 19 | $1,379 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 87 | 89 | Under 11 | $2,222 |
| Eliquis Apixaban | 86 | 86 | Under 11 | $25K |
| Chlorhexidine Gluconate Generic | 78 | 78 | 12 | $1,047 |
| Levothyroxine Sodium Generic | 72 | 73 | Under 11 | $720 |
| Metformin Hcl Generic | 65 | 65 | Under 11 | $516 |
| Pantoprazole Sodium Generic | 63 | 63 | 11 | $9,551 |
| Tamsulosin Hcl Generic | 58 | 59 | Under 11 | $556 |
| Furosemide Generic | 55 | 55 | Under 11 | $398 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 54 | 55 | Under 11 | $2,597 |
Brand drugs: 722 claims; generic drugs: 2,188 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jamshid Niknam $908 ($908 in general payments such as food, travel and fees) from 13 companies. The largest payer was GlaxoSmithKline, LLC. with $350.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 14 | $350 |
| Electromed, Inc. ELMD | 6 | $80.37 |
| Insmed, Inc. INSM | 3 | $79.8 |
| Actelion Pharmaceuticals US, Inc. JNJ | 3 | $78.66 |
| Genzyme Corporation SNY | 2 | $77.67 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $41.92 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $34.87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32.5 |
| Lilly USA, LLC LLY | 1 | $31.2 |
| Mallinckrodt Hospital Products Inc. | 1 | $30.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.